CNR Institutional Research Information System

GAGGINI, MELANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.948
NA - Nord America 1.577
EU - Europa 634
SA - Sud America 384
Continente sconosciuto - Info sul continente non disponibili 260
AF - Africa 36
OC - Oceania 1
Totale 4.840
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.493
SG - Singapore 682
CN - Cina 461
IT - Italia 303
BR - Brasile 298
VN - Vietnam 220
HK - Hong Kong 205
FR - Francia 84
JP - Giappone 84
BD - Bangladesh 80
KR - Corea 72
FI - Finlandia 41
NL - Olanda 39
CA - Canada 36
DE - Germania 34
GB - Regno Unito 33
AR - Argentina 28
IN - India 27
EC - Ecuador 24
ID - Indonesia 23
MX - Messico 18
IQ - Iraq 16
ES - Italia 15
IE - Irlanda 12
PL - Polonia 10
SA - Arabia Saudita 10
VE - Venezuela 10
ZA - Sudafrica 10
AT - Austria 9
IL - Israele 9
MA - Marocco 9
RU - Federazione Russa 8
TR - Turchia 8
CO - Colombia 7
PE - Perù 7
SE - Svezia 7
TW - Taiwan 7
HN - Honduras 6
LT - Lituania 6
TN - Tunisia 6
CR - Costa Rica 5
JM - Giamaica 5
TH - Thailandia 5
UA - Ucraina 5
CL - Cile 4
DK - Danimarca 4
KZ - Kazakistan 4
PH - Filippine 4
RO - Romania 4
BH - Bahrain 3
CH - Svizzera 3
EE - Estonia 3
EG - Egitto 3
JO - Giordania 3
LB - Libano 3
MY - Malesia 3
NI - Nicaragua 3
SV - El Salvador 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BS - Bahamas 2
CZ - Repubblica Ceca 2
GE - Georgia 2
LK - Sri Lanka 2
NP - Nepal 2
PK - Pakistan 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BW - Botswana 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
LC - Santa Lucia 1
MD - Moldavia 1
ML - Mali 1
NA - Namibia 1
NG - Nigeria 1
NO - Norvegia 1
PS - Palestinian Territory 1
SI - Slovenia 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
VG - Isole Vergini Britanniche 1
Totale 4.582
Salva come PNG Salva come JPEG
Città #
Singapore 424
Santa Clara 215
San Jose 214
Hong Kong 202
Hefei 164
Ashburn 157
Beijing 99
Los Angeles 89
Lauterbourg 74
Tokyo 73
Seoul 70
Ho Chi Minh City 66
Hanoi 60
Cascina 51
Pisa 51
Dallas 45
New York 43
São Paulo 34
Milan 23
Lappeenranta 21
Phoenix 21
Buffalo 20
Council Bluffs 20
Atlanta 19
Orem 19
Denver 18
Chicago 17
Florence 17
Frankfurt am Main 15
Helsinki 14
Amsterdam 13
Philadelphia 13
Rio de Janeiro 13
Boston 12
Brooklyn 12
Dublin 12
Houston 12
Naples 12
Rome 12
Quito 11
Charlotte 10
Da Nang 9
Minamishinagawa 9
Montreal 9
Vienna 9
Warsaw 9
City of London 8
Fortaleza 8
Haiphong 8
Hải Dương 8
Belo Horizonte 7
Bengaluru 7
Campinas 7
Lima 7
Stockholm 7
Toronto 7
Bologna 6
Guayaquil 6
London 6
Lucca 6
Miami 6
Turku 6
Biên Hòa 5
Brasília 5
Buenos Aires 5
Changsha 5
Chennai 5
Guangzhou 5
Madrid 5
Norfolk 5
Queens 5
Vũng Tàu 5
Baghdad 4
Belém 4
Boardman 4
Caracas 4
Curitiba 4
Düsseldorf 4
Falkenstein 4
Floyds Knobs 4
Ha Long 4
Jonesboro 4
Mexico City 4
Mississauga 4
Mumbai 4
Munich 4
Poplar 4
Ribeirão Preto 4
San Francisco 4
San José 4
Shanghai 4
Vilnius 4
Albany 3
Altamura 3
Amman 3
Ankara 3
Baltimore 3
Bari 3
Brandon 3
Bắc Giang 3
Totale 2.796
Salva come PNG Salva come JPEG
Nome #
Subjects with non alcoholic fatty liver disease (NAFLD) display increased visceral and pancreatic fat associated with worse metabolic profile 204
Metabolic Syndrome, Thyroid Dysfunction, and Cardiovascular Risk: The Triptych of Evil 170
Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk 111
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance 104
Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia 99
Vitamin D Determinants, Status, and Antioxidant/ Antiinflammatory-Related Effects in Cardiovascular Risk and Disease: Not the LastWord in the Controversy 97
The Thyroid-Oxidative Stress Axis in Heart Failure 93
New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions 87
Changes in plasma bioactive lipids and inflammatory markers during a half-marathon in trained athletes 82
Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars 82
FIB-4 Index and Neutrophil-to-Lymphocyte-Ratio as Death Predictor in Coronary Artery Disease Patients 78
Ceramides as mediators of oxidative stress and inflammation in cardiometabolic disease 77
The Nonalcoholic Steatohepatitis Metabotype: Imbalance of Circulating Amino Acids and Transamination Reactions Reflect Impaired Mitochondrial Function REPLY 76
Lipoprotein(a), Cardiovascular Events and Sex Differences: A Single Cardiological Unit Experience 74
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals 73
Lipidomic analysis to assess the correlation between ceramides, stress hyperglycemia, and HbA1c in acute myocardial infarction 72
PPAR-γ-induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH 71
Casi d’Uso per APP eSDL: Aggiunta nuovi Locali Aggiornamento Procedure di Servizio SSPR IFC-CNR 71
Biomonitoring of Bis(2-ethylhexyl)phthalate (DEHP) in Italian children and adolescents: Data from LIFE PERSUADED project 69
Data mining of key genes expression in hepatocellular carcinoma: novel potential biomarkers of diagnosis prognosis or progression 68
Increased hepatic glucose production and insulin resistance are associated to increased plasma concentrations of glucogenic amino acids in subjects with NAFLD 68
Systemic Immune-Inflammation Index and Systemic Inflammatory Response Index as Predictors of Mortality in ST-Elevation Myocardial Infarction 67
Concordance between indirect fibrosis and steatosis indices and their predictors in subjects with overweight/obesity 66
LACK OF NLRP3-INFLAMMASOME LEADS TO GUT-LIVER AXIS DERANGEMENT AND INCREASES HEPATIC INJURY IN A MOUSE MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE 65
Angiopoietin like protein 4 (ANGPTL4): a marker of alteration in lipid metabolism, insulin resistance and ectopic fat accumulation 65
Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P 64
Oxidative stress biomarkers in the relationship between type 2 diabetes and air pollution 64
Advanced glycation end products, leukocyte telomere length, and mitochondrial DNA copy number in patients with coronary artery disease and alterations of glucose homeostasis: From the GENOCOR study 62
H2S as a Bridge Linking Inflammation, Oxidative Stress and Endothelial Biology: A Possible Defense in the Fight against SARS-CoV-2 Infection? 61
Expression profile of adrenomedullin and its specific receptors in liver tissues from patients with hepatocellular carcinoma and in tumorigenic cell line-secreted extracellular vesicles 61
Ceramides and Cardiovascular Risk Factors, Inflammatory Parameters and Left Ventricular Function in AMI Patients 60
Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease 60
Comparison between galectin-3 and YKL-40 levels for the assessment of liver fibrosis in cirrhotic patients 60
EVALUATION OF METABOLIC PARAMETERS OF HEPATIC DYSFUNCTION IN SUBJECTS WITH HEPATOCELLULAR CARCINOMA AND THEIR CHANGE AFTER LIVER TRANSPLANTATION: A METABOLOMIC APPROACH 60
Increased FNDC5/Irisin expression in human hepatocellular carcinoma 59
Evaluation of published clinical scores for the prediction of cardiometabolic risk in the SEMEOTICONS project 58
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease 56
Inflammatory Biomarkers are Correlated with Some Forms of Regressive Autism Spectrum Disorder 55
Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study 55
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease 54
Mechanisms for increased risk of diabetes in chronic liver diseases 53
Cardiometabolic risk and subclinical vascular damage assessment in idiopathic inflammatory myopathies: a challenge for the clinician 53
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease 53
Brown versus white fat: are they really playing a role in obesity and cardiometabolic risk? "Brown adipose tissue plays a key role in thermogenesis..." 52
The Dark Triad of Particulate Matter, Oxidative Stress and Coronary Artery Disease: What About the Antioxidant Therapeutic Potential 52
Interplay between Vitamin D and Sphingolipids in Cardiometabolic Diseases 51
Altered metabolic profile and adipocyte insulin resistance mark severe liver fibrosis in patients with chronic liver disease 51
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests 50
Plasma Ceramides Pathophysiology, Measurements, Challenges, and Opportunities 50
Osteoprotegerin as a marker of atherosclerosis and severity of CAD in patients candidate to cardiac imaging. 49
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD (vol 7, 12200, 2017) 49
The Sphingolipid-Signaling Pathway as a Modulator of Infection by SARS-CoV-2 48
Do pentraxin 3 and neural pentraxin 2 have different facet function in hepatocellular carcinoma? 45
Effects of Probiotic Supplementationon Gastrointestinal, Sensory and Core Symptoms in Autism Spectrum Disorders: A Randomized Controlled Trial 45
Hepatic macrophage activation is associated with adipose tissue insulin resistance in non-diabetic patients with Non-Alcoholic Fatty Liver Disease 45
Small intestinal metabolism is central to whole-body insulin resistance 43
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease 43
Vitamin D and Ceramide Metabolomic Profile in Acute Myocardial Infarction 43
Squadra di Emergenza - APP per il Rapporto Periodico dei presidi Antincendio - NewSE v1.2 42
Lipids Metabolism and Cardiometabolic Diseases 41
Type 2 Diabetes and Oxidative Stress and Inflammation: Pathophysiological Mechanisms and Possible Therapeutic Options 41
Glucose metabolism in high-risk subjects for type 2 diabetes carrying the rs7903146 TCF7L2 gene variant 39
Insulin resistance and cardiometabolic indexes: comparison of concordance in working-age subjects with overweight and obesity 39
Evaluation of Apelin/APJ system expression in hepatocellular carcinoma as a function of clinical severity 38
The subtle balance between lipolysis and lipogenesis: A critical point in metabolic homeostasis 38
Pericardial fat but not calcium score correlates with oxidative products in patients with known coronary artery disease 38
Increased lipotoxicity and insulin resistance in non diabetic patients with hepatocellular carcinoma 37
Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma. 36
Angiopoietin-Like Protein 4 Overexpression in Visceral Adipose Tissue from Obese Subjects with Impaired Glucose Metabolism and Relationship with Lipoprotein Lipase 36
Glucose kinetics: an update and novel insights into its regulation by glucagon and GLP-1. 35
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms 34
Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease 34
HCC Development Is Associated to Peripheral Insulin Resistance in a Mouse Model of NASH 34
Insulin resistance and endothelial dysfunction: a mutual relationship in cardiometabolic risk 33
Insights into the Roles of GLP-1, DPP-4, and SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology 32
Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity 31
Conventional and innovative methods to assess oxidative stress biomarkers in the clinical cardiovascular setting 30
A 2,3-diphenylpyrido[1,2-a] pyrimidin-4-one derivative inhibits specific angiogenic factors induced by TNF-? 27
Ectopic fat: a target for cardiometabolic risk management 26
Chronic intranasal insulin does not affect hepatic lipids but lowers circulating BCAAs in healthy male subjects 26
Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism Study. 25
Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up 25
Osteoprotegerin as optimal target for the screening of patients with hepatocellular carcinoma at higher risk of mortality 25
The color of fat and its central role in the development and progression of metabolic diseases 25
Ectopic fat: the true culprit linking obesity and cardiovascular disease? 20
Totale 4.840
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.117
article - articoli 15.469
book - libri 228
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.814
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202480 0 0 0 0 0 0 0 0 30 19 16 15
2024/20251.382 25 13 102 102 267 59 48 96 62 56 320 232
2025/20262.777 110 354 172 402 474 140 321 140 184 181 173 126
2026/2027601 182 105 314 0 0 0 0 0 0 0 0 0
Totale 4.840